Use of Statistics to Assess the Global Burden of Breast Cancer

Abstract:  A variety of statistics are used to quantify the burden (occurrence and outcome) of cancer generally and of breast cancer specifically. When undertaking any cancer control program, understanding these statistics, their source, and their quality is important for assessing the current situation, allocating resources to different control strategies, and evaluating progress. Two core statistics are the cancer incidence rate and the cancer mortality rate, which provide estimates of the average risk of acquiring and of dying from the disease, respectively. About 16% of the world's population is covered by registration systems that produce cancer incidence statistics, while mortality data are available for about 29%. Breast cancer incidence and mortality vary considerably by world region. In general, the incidence is high (greater than 80 per 100,000) in developed regions of the world and low (less than 30 per 100,000), though increasing, in developing regions; the range of mortality rates is much less (approximately 6–23 per 100,000) because of the more favorable survival of breast cancer in (high‐incidence) developed regions. The incidence of breast cancer is increasing almost everywhere. This unfavorable trend is due in part to increases in risk factors (decreased childbearing and breast‐feeding, increased exogenous hormone exposure, and detrimental dietary and lifestyle changes, including obesity and less physical activity). On the other hand, mortality is now decreasing in many high‐risk countries due to a combination of intensified early detection efforts and the introduction of mammographic screening, resulting in the diagnosis of more small, early stage tumors, and advances in treatment.

[1]  NATIONAL CANCER INSTITUTE OF CANADA. , 1949, Canadian Medical Association journal.

[2]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[3]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[4]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[5]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[6]  J. Yarnold,et al.  Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Joan M. Anderson Migration and health: perspectives on immigrant women. , 1987 .

[8]  M Baum,et al.  Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[9]  A. Korzun,et al.  Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Alexander Estimation of sojourn time distributions and false negative rates in screening programmes which use two modalities. , 1989, Statistics in medicine.

[11]  D. Parkin Cancers of the breast, endometrium and ovary: geographic correlations. , 1989, European journal of cancer & clinical oncology.

[12]  Terry L. Smith,et al.  Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? , 1990, Cancer.

[13]  H. D. de Koning,et al.  Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.

[14]  L. Sanderson,et al.  Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[15]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[16]  D. Morisky,et al.  Mammography Usage and the Health Belief Model , 1992, Health education quarterly.

[17]  A M Nomura,et al.  Migration patterns and breast cancer risk in Asian-American women. , 1993, Journal of the National Cancer Institute.

[18]  Jacques Estève,et al.  Trends in cancer incidence and mortality. , 2009 .

[19]  S. Hopper,et al.  The influence of ethnicity on the health of older women. , 1993, Clinics in geriatric medicine.

[20]  D. Parkin,et al.  Cancer in Italian Migrant Populations , 1993 .

[21]  M. Gerretsen,et al.  A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.

[22]  T. Landberg,et al.  The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. , 1993, Acta oncologica.

[23]  M Baum,et al.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Coebergh,et al.  Is the peak in breast cancer incidence in sight? A study conducted in the southeastern Netherlands. , 1994, European journal of cancer.

[25]  P. Rheinstein,et al.  The Mammography Quality Standards Act of 1992. , 1994, American family physician.

[26]  P. Boffetta,et al.  Cancer in developing countries , 1994, CA: a cancer journal for clinicians.

[27]  Mike Clarke,et al.  EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .

[28]  K Smigel,et al.  Breast cancer death rates decline for white women. , 1995, Journal of the National Cancer Institute.

[29]  A. Tamakoshi,et al.  Epidemiology of breast cancer in Japan. , 1995, International journal of epidemiology.

[30]  C. Sargent,et al.  Gender and Health: An International Perspective , 1995 .

[31]  Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

[32]  M Quinn,et al.  Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening , 1995, BMJ.

[33]  Latino male attitudes and behaviors on their spouses' and partners' cancer-screening behavior: focus group findings. , 1995, Journal of the National Cancer Institute. Monographs.

[34]  W. Chie,et al.  Age-period-cohort analysis of breast cancer mortality. , 1995, Anticancer research.

[35]  F. Houn,et al.  The Mammography Quality Standards Act of 1992. History and philosophy. , 1995, Radiologic clinics of North America.

[36]  B A Miller,et al.  Recent trends in U.S. breast cancer incidence, survival, and mortality rates. , 1996, Journal of the National Cancer Institute.

[37]  J. Bonneterre,et al.  A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine. , 1996, PharmacoEconomics.

[38]  J. Kelsey,et al.  Epidemiology and prevention of breast cancer. , 1996, Annual review of public health.

[39]  R. Roetzheim,et al.  The effects of health beliefs on screening mammography utilization among a diverse sample of older women. , 1997, Women & health.

[40]  V. Champion,et al.  Recent mammography in women aged 35 and older: predisposing variables. , 1996, Health care for women international.

[41]  R. Peto Five years of tamoxifen--or more? , 1996, Journal of the National Cancer Institute.

[42]  S. Duffy,et al.  Breast cancer in Singapore: trends in incidence 1968-1992. , 1996, International journal of epidemiology.

[43]  B. Borman,et al.  Breast cancer in New Zealand: trends, patterns, and data quality. , 1996, The New Zealand medical journal.

[44]  A. Recht,et al.  The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. , 1996, The New England journal of medicine.

[45]  M. A. Trapp,et al.  A program to increase breast and cervical cancer screening for Cambodian women in a midwestern community. , 1996, Mayo Clinic proceedings.

[46]  P Selby,et al.  Benefits from specialised cancer care , 1996, The Lancet.

[47]  A. Garber,et al.  Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.

[48]  Eero Pukkala,et al.  Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.

[49]  J. Benichou,et al.  Ethnicity and variation in breast cancer incidence , 1997 .

[50]  W. Holzemer,et al.  Helpseeking for self-discovered breast symptoms. Implications for early detection. , 1997, Cancer practice.

[51]  A. Avgar Women's health in Israel: a feminist perspective. , 1997, Social work in health care.

[52]  D. Stockton,et al.  Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment? , 1997, BMJ.

[53]  A. Gregor,et al.  Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  Richard A. Krueger,et al.  Analyzing and Reporting Focus Group Results , 1997 .

[55]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[56]  R. Sankaranarayanan Cancer Survival in Developing Countries , 1998 .

[57]  H. Adami,et al.  Recent trends in breast cancer incidence in Sweden , 1998 .

[58]  N. Day,et al.  Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis , 1998, Journal of medical screening.

[59]  Mireille J. M. Broeders,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .

[60]  C. Murray,et al.  Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  K I Bland,et al.  The National Cancer Data Base 10‐year survey of breast carcinoma treatment at hospitals in the United States , 1998, Cancer.

[62]  D. Parkin,et al.  An overview of cancer survival in developing countries. , 1998, IARC scientific publications.

[63]  J. Walley,et al.  Assessing health needs in developing countries , 1998, BMJ.

[64]  A. Kricker,et al.  Breast cancer mortality trends in Australia: 1921 to 1994 , 1998, The Medical journal of Australia.

[65]  S. Shapiro,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. , 1998, International journal of epidemiology.

[66]  A. Kricker,et al.  Breast cancer in New South Wales in 1972–1995: Tumor size and the impact of mammographic screening , 1999, International journal of cancer.

[67]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[68]  E. Rutten,et al.  Erratum to “ The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study” [Radiother. Oncol. 52 (1999) 101–109]☆ , 1999 .

[69]  S. Underwood,et al.  Veiled yet vulnerable. Breast cancer screening and the Muslim way of life. , 1999, Cancer practice.

[70]  J. Norum,et al.  Breast cancer screening by mammography in Norway. Is it cost-effective? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[71]  L. Remennick Breast screening practices among Russian immigrant women in Israel. , 1999, Women & health.

[72]  M. Somerfield,et al.  American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  A. Meghzifene,et al.  Radiation therapy in Africa: distribution and equipment. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[74]  S. Devesa,et al.  Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. , 1999, Journal of the National Cancer Institute.

[75]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[76]  D. Parkin,et al.  Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997 , 2000, British Journal of Cancer.

[77]  Mike Clarke,et al.  UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years , 2000, The Lancet.

[78]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.

[79]  Omar M. Salazar,et al.  Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). , 2000 .

[80]  K McPherson,et al.  Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.

[81]  L Collette,et al.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[83]  D B Evans,et al.  Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[85]  S. Redman,et al.  Evaluating the effectiveness of advocacy training for breast cancer advocates in Australia. , 2001, European journal of cancer care.

[86]  J. V. van Engelshoven,et al.  Diagnostic value of radiological breast imaging in a non‐screening population , 2001, International journal of cancer.

[87]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[88]  H. Tatsuzaki,et al.  Quantitative status of resources for radiation therapy in Asia and Pacific region. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[89]  L. Remennick All my life is one big nursing home , 2001 .

[90]  D. Peterson,et al.  Needs Assessment in Public Health: A Practical Guide for Students and Professionals , 2001 .

[91]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[92]  Roberta M Ray,et al.  Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.

[93]  T. Whelan,et al.  Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer , 2002 .

[94]  Alan D. Lopez,et al.  Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site , 2002, BMC Cancer.

[95]  Paola Pisani,et al.  Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.

[96]  H. Tatsuzaki,et al.  Radiotherapy services in countries in transition: gross national income per capita as a significant factor. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[97]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[98]  Efficacy, toxicity, and cost-effectiveness of single-dose versus fractionated hemibody irradiation (HBI). , 2002, International journal of radiation oncology, biology, physics.

[99]  Alan D. Lopez,et al.  Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000 , 2002, BMC Cancer.

[100]  Radiotherapy in the management of early breast cancer in Ibadan: outcome of chest wall irradiation alone in clinically nodes free axilla. , 2002, African journal of medicine and medical sciences.

[101]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[102]  A. Hedley,et al.  Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis , 2002, British Journal of Cancer.

[103]  A. Bener,et al.  The determinants of breast cancer screening behavior: a focus group study of women in the United Arab Emirates. , 2002, Oncology nursing forum.

[104]  L. Brinton,et al.  Recent trends in breast cancer incidence and mortality , 2002, Environmental and molecular mutagenesis.

[105]  Rob Baltussen,et al.  Programme costs in the economic evaluation of health interventions , 2003, Cost effectiveness and resource allocation : C/E.

[106]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[107]  D Hölzel,et al.  The process of metastasisation for breast cancer. , 2003, European journal of cancer.

[108]  Stephen Taplin,et al.  Early Detection of Breast Cancer in Countries with Limited Resources , 2003, The breast journal.

[109]  D. Radice,et al.  Breast cancer management: quality-of-life and cost considerations. , 2003, PharmacoEconomics.

[110]  Anthony Rodgers,et al.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.

[111]  D. Parkin,et al.  Cancer in Africa : epidemiology and prevention , 2003 .

[112]  Christopher J L Murray,et al.  WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.

[113]  C. Holt,et al.  Development of a spiritually based breast cancer educational booklet for African American women. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[114]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[115]  Roman Shyyan,et al.  Introduction of Breast Cancer Screening in Chernihiv Oblast in the Ukraine: Report of a PATH Breast Cancer Assistance Program Experience , 2003, The breast journal.

[116]  B. Green,et al.  The perspective of African‐American breast cancer survivor‐advocates , 2003, Cancer.

[117]  S. Braun The History of Breast Cancer Advocacy , 2003, The breast journal.

[118]  Lisa Barbera,et al.  Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[119]  D. Parkin,et al.  Time trends in cancer mortality in China: 1987–1999 , 2003, International journal of cancer.

[120]  A. Miller,et al.  Why is breast-cancer mortality declining? , 2003, The Lancet. Oncology.

[121]  G. Giles,et al.  Evaluation of the organised mammographic screening programme in Australia. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[122]  Taghreed Adam,et al.  Cost Effectiveness and Resource Allocation Econometric Estimation of Country-specific Hospital Costs , 2003 .

[123]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.

[124]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[125]  B. Stewart,et al.  World Cancer Report , 2003 .

[126]  Guilbert Jj The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[127]  L. Tabár,et al.  The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. , 2003, European journal of cancer.

[128]  B. Yeole,et al.  An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. , 2003, Asian Pacific journal of cancer prevention : APJCP.

[129]  G. Dziekan,et al.  The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings. , 2003, Bulletin of the World Health Organization.

[130]  F. Bray,et al.  Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.

[131]  C. Nagata,et al.  Trends in the incidence rate and risk factors for breast cancer in Japan , 1997, Breast Cancer Research and Treatment.

[132]  L. Remennick “I Have No Time for Potential Troubles”: Russian Immigrant Women and Breast Cancer Screening in Israel , 2003, Journal of Immigrant Health.

[133]  Rob Baltussen,et al.  Accounting for the cost of scaling-up health interventions. , 2004, Health economics.

[134]  T. Holford Trends in cancer incidence and mortality , 1995, Cancer Causes & Control.

[135]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[136]  H. Bartelink,et al.  The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial , 2004 .

[137]  E. Feuer,et al.  Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? , 1995, Cancer Causes & Control.

[138]  K. Hess,et al.  Surgical treatment of metastatic brain tumors , 1996, Journal of Neuro-Oncology.

[139]  R. Baltussen,et al.  Cost-effectiveness analysis of cataract surgery: a global and regional analysis. , 2004, Bulletin of the World Health Organization.

[140]  Breast cancer advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition. , 2004, European journal of cancer.

[141]  Carmen DeNavas-Walt,et al.  Income, Poverty, and Health Insurance Coverage in the United States: 2004 , 2006 .

[142]  E. Borrayo,et al.  Are All Latinas the Same? Perceived Breast Cancer Screening Barriers and Facilitative Conditions , 2004 .

[143]  David Rajasekar,et al.  Improvement of radiotherapy facilities in developing countries: a three-tier system with a teleradiotherapy network. , 2004, The Lancet. Oncology.

[144]  A. Taghian,et al.  Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[145]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[146]  H. Bartelink,et al.  The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[147]  G. Hortobagyi,et al.  Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[148]  E. Eng,et al.  Natural helping functions of lay health advisors in breast cancer education , 2004, Breast Cancer Research and Treatment.

[149]  D. Zaridze,et al.  Incidence of cancer of the lung stomach, breast, and cervix in the USSR: pattern and trends , 1990, Cancer Causes & Control.

[150]  A. Walker,et al.  Breast cancer in black African women: a changing situation , 2004, The journal of the Royal Society for the Promotion of Health.

[151]  R. Jagsi,et al.  Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. , 2003, International journal of radiation oncology, biology, physics.

[152]  Iris Pigeot,et al.  Handbook of epidemiology , 2005 .

[153]  J. Bellon,et al.  Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[154]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[155]  John J Spinelli,et al.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. , 2005, Journal of the National Cancer Institute.

[156]  N. Beşe,et al.  The Effect of Treatment Interruptions in the Postoperative Irradiation of Breast Cancer , 2005, Oncology.

[157]  B. Vikram,et al.  Breast Cancer in Limited‐Resource Countries: Treatment and Allocation of Resources , 2006, The breast journal.

[158]  I. Nyirjesy Enthusiasm for Cancer Screening in the United States , 2008 .